Pain Control During Braces Removal Using Transcutaneous Electrical Nerve Stimulation and High-Frequency Vibration
Assessment of Transcutaneous Electrical Nerve Stimulation and High-Frequency Vibration for Pain Control During Bracket Debonding: A Clinical Trial Study
1 other identifier
interventional
90
1 country
1
Brief Summary
This study aims to find the best method to reduce pain during braces removal. We are comparing transcutaneous electrical nerve stimulation (TENS), high-frequency vibration, and a control group with no additional intervention. People who have completed orthodontic treatment and need their braces removed can take part. Participants will be randomly assigned to one of the three groups. The vibration device will be applied during the braces removal, while TENS will be applied just before the procedure. Before the procedure, participants' anxiety will be measured using the Modified Dental Anxiety Scale (MDAS). During and after the procedure, pain will be assessed using a Visual Analog Scale (VAS) from 0 to 100, and participants will rate their satisfaction using a Numerical Rating Scale (NRS) from 0 to 10. The purpose of this research is to help orthodontists identify the method that makes braces removal less uncomfortable, more tolerable, and more satisfying for patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 20, 2026
December 1, 2025
5 months
December 9, 2025
April 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain During Orthodontic Debonding Measured by VAS
Pain during debonding will be measured immediately after the procedure using VAS 0-100 mm, where 0 = no pain and 100 = worst imaginable pain.
During and immediately after debonding procedure
Secondary Outcomes (4)
Baseline Anxiety
Prior to the debonding procedure
Patient Satisfaction
immediately post-procedure
Device Application Time
Periprocedural (during the debonding session)
Cost-Effectiveness Analysis
Periprocedural (during the debonding session) and at immediate post-procedure assessment.
Study Arms (3)
Transcutaneous Electrical Nerve Stimulation (TENS)
EXPERIMENTALParticipants in this arm will receive transcutaneous electrical nerve stimulation (TENS) applied immediately before orthodontic bracket removal. Pain, satisfaction, and procedural efficiency will be assessed during a single session.
High-Frequency Vibration (SureSmile® VPro™)
EXPERIMENTALParticipants in this arm will receive high-frequency vibration applied during orthodontic bracket removal. Pain, satisfaction, and procedural efficiency will be assessed during a single session.
No Intervention
NO INTERVENTIONParticipants in this arm will undergo standard orthodontic bracket removal without any additional device. Pain, satisfaction, and procedural efficiency will be assessed during a single session.
Interventions
TENS is applied immediately before orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.
High-frequency vibration is applied during orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.
Eligibility Criteria
You may qualify if:
- Patients scheduled for fixed orthodontic appliance removal.
- Permanent dentition present, including both anterior and posterior teeth.
- Age between 15-35 years.
- Ability to provide informed consent and comply with study procedures.
- General health adequate for routine orthodontic care.
- No history of regular or recent medication intake within the preceding 24 hours, including painkillers, corticosteroids, or anti-flu drugs.
You may not qualify if:
- Patients with craniofacial anomalies, systemic conditions affecting pain perception, or taking medications influencing nociception.
- Teeth with extensive restorations or prostheses that prevent standard bracket debonding.
- Patients with known allergy or contraindication to TENS or vibration devices.
- Pregnant women.
- Active periodontal disease, including gingival recession or tooth mobility exceeding Grade I.
- Excessive gingival overgrowth that may impede debonding or influence study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Dentistry, University of Baghdad
Baghdad, Iraq
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali M. Al-Attar, BDS, MSc, PhD
University of Baghdad - College of Dentistry - Orthodontics
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Student Researcher
Study Record Dates
First Submitted
December 9, 2025
First Posted
December 19, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 20, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
There is currently no definitive plan to share Individual Participant Data (IPD). However, IPD may be made available in the future if required by the journal in which the results are published, subject to ethical approval, institutional regulations, and obtaining appropriate patient consent. All shared data will be de-identified to protect participant confidentiality.